Highlight report: Imaging of bile ducts and the bile canalicular network
Regina Stoeber11Leibniz Research Centre for Working Environment and Human Factors
EXCLI J 2019;18:Doc477
Cholestasis is defined as reduced bile flux, either caused by an obstruction of bile ducts or by compromised hepatocellular secretion (Pollheimer et al., 2014; Fickert et al., 2014; Slitt et al., 2007; Jansen et al., 2017). In the acute phase of obstructive cholestasis ruptures of the apical (bile canaliculi forming) hepatocyte membranes occur that lead to bile salt rich necrotic regions, the so-called bile infarcts (Ghallab et al., 2019). In the chronic phase, the biliary tree undergoes massive remodeling by branching of interlobular ducts and re-looping so that an initially sparse network around portal veins transforms into a much denser network (Vartak et al., 2016). For a better understanding of the complex architectural changes it is necessary to 3D-reconstruct and quantify the changes during cholestasis. For this purpose, Damle-Vartak and colleagues recently published a protocol to visualize the finest domains of the biliary network, bile canaliculi and interlobular ducts, based on immunofluorescence, 3D-confocal imaging, surface reconstruction and quantitative morphometry (Damle-Vartak et al., 2019). The method is applicable to all types of liver injury and can be used for cleared tissue of approximately 500 µm thick sections.
One important discovery made by this method is that the most upstream domain of the biliary tract, bile canaliculi, responds differently to cholestasis than the more downstream interlobular ducts (Damle-Vartak et al., 2019). Bile canaliculi adopt wider diameters and form spine-like protrusions; while the ducts undergo elongation, branching and looping to form a denser mesh without increasing their diameters.
Recently, much effort has been invested to gain a better understanding of cholestasis (Ehrlich and Glaser, 2018; Pradhan-Sundd et al., 2018; Sultan et al., 2018; Thompson et al., 2018) and associated hepatotoxicity (Sezgin et al., 2018; Leist et al., 2017; Grinberg et al., 2014; Godoy et al., 2013). Often, these studies require quantitative image analysis as a precondition for mathematical modeling (Hoehme et al., 2010, 2017; Hammad et al., 2014; Schliess et al., 2014; Ghallab et al., 2016). The just published protocols (Damle-Vartak et al., 2019) offer excellent preconditions to study the spatial responses of the biliary tree and can in principle be applied to analyze any 3D-conduit-like structure.
Conflict of interest
The author declares no conflict of interest.
1. Damle-Vartak A, Begher-Tibbe B, Gunther G, Geisler F, Vartak N, Hengstler JG. pipe-3d: a pipeline based on immunofluorescence, 3d confocal imaging, reconstructions, and morphometry for biliary network analysis in cholestasis. Methods Mol Biol. 2019;1981:25-53.
2. Ehrlich L, Glaser SS. Novel β-catenin/farnesoid X receptor interaction regulates hepatic bile acid metabolism during cholestasis. Hepatology. 2018;67:829-32.
3. Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, et al. Characterization of animal models for primary sclerosing cholangitis (PSC). J Hepatol. 2014;60:1290‐1303.
4. Ghallab A, Cellière G, Henkel SG, Driesch D, Hoehme S, Hofmann U, et al. Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases. J Hepatol. 2016;64:860-71.
5. Ghallab A, Hofmann U, Sezgin S, Vartak N, Hassan R, Zaza A, et al. Bile micro-infarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood. Hepatology. 2019;69:666-83.
6. Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013;87:1315-530.
7. Grinberg M, Stöber RM, Edlund K, Rempel E, Godoy P, Reif R, et al. Toxicogenomics directory of chemically exposed human hepatocytes. Arch Toxicol. 2014;88:2261-87.
8. Hammad S, Hoehme S, Friebel A, von Recklinghausen I, Othman A, Begher-Tibbe B, et al. Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis. Arch Toxicol. 2014;88:1161-83.
9. Hoehme S, Brulport M, Bauer A, Bedawy E, Schormann W, Hermes M, et al. Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration. Proc Natl Acad Sci U S A. 2010;107:10371-6.
10. Hoehme S, Friebel A, Hammad S, Drasdo D, Hengstler JG. Creation of three-dimensional liver tissue models from experimental images for systems medicine. Methods Mol Biol. 2017;1506:319-62.
11. Jansen PL, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, et al. The ascending pathophysiology of cholestatic liver disease. Hepatology. 2017;65:722-38.
12. Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, et al. Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol. 2017;91:3477-505.
13. Pollheimer MJ, Fickert P, Stieger B. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis. Mol Aspects Med. 2014;37:35‐56.
14. Pradhan-Sundd T, Zhou L, Vats R, Jiang A, Molina L, Singh S, et al. Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis. Hepatology. 2018;67:2320-37.
15. Schliess F, Hoehme S, Henkel SG, Ghallab A, Driesch D, Böttger J, et al. Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration. Hepatology. 2014;60:2040-51.
16. Sezgin S, Hassan R, Zühlke S, Kuepfer L, Hengstler JG, Spiteller M, et al. Spatio-temporal visualization of the distribution of acetaminophen as well as its metabolites and adducts in mouse livers by MALDI MSI. Arch Toxicol. 2018;92:2963-77.
17. Slitt AL, Allen K, Morrone J, Aleksunes LM, Chen C, Maher JM, et al. Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. Biochim Biophys Acta. 2007;1768:637-47.
18. Sultan M, Rao A, Elpeleg O, Vaz FM, Abu-Libdeh B, Karpen SJ, et al. Organic solute transporter-β (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis. Hepatology. 2018;68:590-8.
19. Thompson MD, Moghe A, Cornuet P, Marino R, Tian J, Wang P, et al. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis. Hepatology. 2018;67:955-71.
20. Vartak N, Damle-Vartak A, Richter B, Dirsch O, Dahmen U, Hammad S, et al. Cholestasis-induced adaptive remodeling of interlobular bile ducts. Hepatology. 2016;63:951-64.